GGTA1 KO Thymokidney for kidney failure, chronic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Nov 2025: Trial registered, NCT07224763

The trials

NCT07224763: Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD

State
Under way
Phase
Phase 1 and Phase 2
People
50 planned
Started
Nov 2026
Primary completion
Nov 2029
Arms
GGTA1 KO Thymokidney
Results
None posted
  1. 5 Nov 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.